HDAC6 and systemic lupus erythematosus: Targeted inhibition of HDAC6 effectively reversed SLE-associated abnormalities by modulating the proportions of cells in the late pro- and early pre-B cell fractions and altering T cell differentiation, as indicated by increased Treg cells and decreased thymic DN T cells (99).